Loading organizations...
§ Private Profile · New York City, NY, USA
Biopharmaceutical company targeting unmet needs in oncology.
Nuvation Bio has raised $375.0M across 2 funding rounds.
Nuvation Bio has raised $375.0M in total across 2 funding rounds.
Nuvation Bio has raised $375.0M across 2 funding rounds. Most recently, it raised $100.0M Debt in March 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 3, 2025 | $100M Debt Financing | Sagard | — | Announced |
| Oct 28, 2019 | $275M Series A | Omega Funds | — | Announced |
Nuvation Bio has raised $375.0M in total across 2 funding rounds.
Nuvation Bio's investors include Sagard, Omega Funds.